Berenberg Bank initiated coverage on shares of Medical Properties Trust (NYSE:MPW) in a research note released on Thursday, The Fly reports. The brokerage issued a buy rating and a $22.00 price target on the real estate investment trust’s stock.

MPW has been the subject of a number of other research reports. Zacks Investment Research lowered shares of Medical Properties Trust from a hold rating to a sell rating in a report on Wednesday, July 17th. ValuEngine lowered shares of Medical Properties Trust from a buy rating to a hold rating in a report on Thursday, August 1st. Deutsche Bank raised shares of Medical Properties Trust from a hold rating to a buy rating in a research report on Monday, July 29th. SunTrust Banks boosted their price target on shares of Medical Properties Trust from $20.00 to $21.00 and gave the company a buy rating in a research report on Tuesday, August 27th. Finally, JPMorgan Chase & Co. set a $21.00 price target on shares of Medical Properties Trust and gave the company a buy rating in a research report on Wednesday, September 4th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have issued a buy rating to the company. The stock presently has a consensus rating of Buy and a consensus target price of $19.59.

NYSE MPW traded down $0.48 on Thursday, hitting $18.46. The company had a trading volume of 4,515,346 shares, compared to its average volume of 3,801,662. The company has a market capitalization of $8.51 billion, a PE ratio of 13.47, a PEG ratio of 3.63 and a beta of 0.56. The company’s fifty day moving average price is $18.24 and its 200-day moving average price is $18.15. The company has a debt-to-equity ratio of 0.99, a current ratio of 8.00 and a quick ratio of 8.00. Medical Properties Trust has a 12-month low of $13.98 and a 12-month high of $19.26.

Medical Properties Trust (NYSE:MPW) last released its earnings results on Thursday, August 1st. The real estate investment trust reported $0.31 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.31. Medical Properties Trust had a net margin of 129.20% and a return on equity of 6.84%. The business had revenue of $192.55 million during the quarter, compared to analyst estimates of $186.11 million. During the same quarter in the prior year, the firm earned $0.36 earnings per share. The company’s revenue for the quarter was down 4.6% compared to the same quarter last year. On average, sell-side analysts anticipate that Medical Properties Trust will post 1.3 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Thursday, October 10th. Stockholders of record on Thursday, September 12th will be given a dividend of $0.26 per share. This is a boost from Medical Properties Trust’s previous quarterly dividend of $0.25. The ex-dividend date is Wednesday, September 11th. This represents a $1.04 annualized dividend and a dividend yield of 5.63%. Medical Properties Trust’s payout ratio is presently 75.91%.

In related news, Director G Steven Dawson bought 7,476 shares of the firm’s stock in a transaction on Thursday, August 8th. The shares were bought at an average price of $18.07 per share, with a total value of $135,091.32. Following the completion of the transaction, the director now directly owns 76,302 shares of the company’s stock, valued at approximately $1,378,777.14. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider R Steven Hamner sold 70,000 shares of the company’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $17.77, for a total transaction of $1,243,900.00. Following the completion of the transaction, the insider now directly owns 1,312,957 shares in the company, valued at approximately $23,331,245.89. The disclosure for this sale can be found here. Insiders own 1.18% of the company’s stock.

Hedge funds and other institutional investors have recently bought and sold shares of the business. Cullen Frost Bankers Inc. lifted its position in Medical Properties Trust by 70.9% in the second quarter. Cullen Frost Bankers Inc. now owns 1,832 shares of the real estate investment trust’s stock valued at $32,000 after buying an additional 760 shares during the last quarter. Manchester Financial Inc. acquired a new position in Medical Properties Trust in the second quarter valued at about $33,000. Princeton Global Asset Management LLC acquired a new position in Medical Properties Trust in the first quarter valued at about $37,000. Cascade Investment Advisors Inc. acquired a new position in Medical Properties Trust in the second quarter valued at about $35,000. Finally, Icon Wealth Partners LLC acquired a new position in Medical Properties Trust in the first quarter valued at about $42,000. 71.37% of the stock is currently owned by institutional investors.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

See Also: Strike Price

The Fly

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.